Cargando…
Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture
Collagenase Clostridium histolyticum (CCH) is a non-surgical, efficacious therapy for Dupuytren's contracture (DC). This study evaluated the efficacy and safety of CCH in patients with previous DC surgery. Data from 12 CCH clinical trials were pooled. At screening, patients provided details abo...
Autores principales: | Bainbridge, Chris, Gerber, Robert A., Szczypa, Piotr P., Smith, Ted, Kushner, Harvey, Cohen, Brian, Le Graverand-Gastineau, Marie-Pierre Hellio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469218/ https://www.ncbi.nlm.nih.gov/pubmed/22670890 http://dx.doi.org/10.3109/2000656X.2012.683795 |
Ejemplares similares
-
Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture
por: Peimer, C. A., et al.
Publicado: (2015) -
Isolated and Spontaneous Correction of Proximal Interphalangeal Joint Contractures in Dupuytren’s Disease: An Exploratory Analysis of the Efficacy and Safety of Collagenase Clostridium histolyticum
por: Hayton, Michael J., et al.
Publicado: (2013) -
Collagenase Dupuytren Contracture: Achieving Single Treatment Success with a Hand Therapist-Based Protocol
por: Malafa, Menyoli M., et al.
Publicado: (2016) -
Hand therapy or not following collagenase treatment for Dupuytren’s contracture? Protocol for a randomised controlled trial
por: Aglen, Terese, et al.
Publicado: (2019) -
Collagenase clostridium histolyticum in patients with Dupuytren’s contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes
por: Warwick, D., et al.
Publicado: (2015)